Key result
COX-2 inhibition reduces ischemic brain injury and PGE2 without lowering postischemic ROS production.
Answers are grounded in this paper and cite their sources.
We sought to determine whether reactive oxygen species (ROS) derived from cyclooxygenase-2 (COX-2) are involved in ischemic brain injury. Focal cerebral ischemia was induced by transient middle cerebral artery occlusion in C57BL/6 mice. The time course of neocortical ROS production was assessed in vivo using hydroethidine as a marker. The same brain sections were used for infarct volume measurements. Transient middle cerebral artery occlusion led to a biphasic increase in ROS production with peaks 2 and 72 h after reperfusion. The COX-2 inhibitor NS398 (10 mg/kg) attenuated the production of COX-2-derived prostaglandin E(2) and reduced brain injury, but did not affect ROS production at 2 and 72 h. Similarly, ROS production was not reduced in COX-2-null mice. In contrast, ROS production and brain injury were reduced in mice lacking the nox2 subunit of the superoxide-producing enzyme nicotinamide adenine dinucleotide phosphate (reduced form) oxidase. The data suggest that COX-2 is not a major source of oxygen radicals after cerebral ischemia and raise the possibility that other COX-2 reaction products, including prostanoids or nonoxygen-based radicals, mediate the COX-2-dependent component of the injury.
No takes yet. Share an insight, caveat, or question.
Kunz et al. (2006) studied Focal cerebral ischemia (transient middle cerebral artery occlusion). NS398 (COX-2 inhibitor) or genetic deletion of COX-2 / nox2 vs. Untreated / wild-type control mice was evaluated on Neocortical reactive oxygen species (ROS) production and brain infarct volume. COX-2 inhibition with NS398 reduced ischemic brain injury and prostaglandin E2 but did not reduce postischemic ROS production at 2 and 72 hours.
Synapse has enriched 10 related papers. Consider them for comparative context: